Cardiac PET imaging of ATP binding cassette (ABC) transporters: opportunities and challenges
W Liu, P Mossel, V Schwach, RHJA Slart, G Luurtsema - Pharmaceuticals, 2023 - mdpi.com
Adenosine triphosphate binding cassette (ABC) transporters are a broad family of
membrane protein complexes that use energy to transport molecules across cells and/or …
membrane protein complexes that use energy to transport molecules across cells and/or …
The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments
C Yu, F Pathan, TC Tan, K Negishi - Frontiers in Cardiovascular …, 2021 - frontiersin.org
Cardio-oncology encompasses the risk stratification, prognostication, identification and
management of cancer therapeutics related cardiac dysfunction (CTRCD). Cardiovascular …
management of cancer therapeutics related cardiac dysfunction (CTRCD). Cardiovascular …
Neurotoxic effect of doxorubicin treatment on cardiac sympathetic neurons
N Moro, L Dokshokova, I Perumal Vanaja… - International Journal of …, 2022 - mdpi.com
Doxorubicin (DOXO) remains amongst the most commonly used anti-cancer agents for the
treatment of solid tumors, lymphomas, and leukemias. However, its clinical use is hampered …
treatment of solid tumors, lymphomas, and leukemias. However, its clinical use is hampered …
Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
There are limited data on the effects of anthracyclines on right ventricular (RV) structure,
function, and tissue characteristics. The goal of this study was to investigate the effects of …
function, and tissue characteristics. The goal of this study was to investigate the effects of …
Detection of right ventricular dysfunction by three–dimensional echocardiography and two-dimensional speckle tracking in breast cancer patients receiving …
WS El-Sherbeny, NM Sabry, SB El-Saied, B Elnagar - Cardio-Oncology, 2023 - Springer
Background Despite the cardiotoxic effect of anthracycline on the left ventricle (LV) was
totally identified. The assessment of the anthracycline effect on the right ventricle (RV) by …
totally identified. The assessment of the anthracycline effect on the right ventricle (RV) by …
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology
K Keramida, D Farmakis, A Rakisheva… - European Journal of …, 2024 - Wiley Online Library
Cardio-oncology guidelines, position statements and clinical trials have focused on the
cardiotoxic effects of cancer therapies upon the left ventricle. 1, 2 However, cancer …
cardiotoxic effects of cancer therapies upon the left ventricle. 1, 2 However, cancer …
Modeling Doxorubicin-Induced-Cardiotoxicity Through Breast Cancer Patient Specific iPSC-derived Heart Organoid
J Jang, H Jung, J Jeong, J Jeon, K Lee, HR Jang… - Heliyon, 2024 - cell.com
Heart organoid (HO) technology has successfully overcome the limitations of two-
dimensional (2D) disease modeling and drug testing, thereby emerging as a valuable tool in …
dimensional (2D) disease modeling and drug testing, thereby emerging as a valuable tool in …
Prevalence of right ventricle strain changes following anthracycline therapy
M Laufer-Perl, M Perelman-Gvili, S Sirota Dorfman… - Life, 2022 - mdpi.com
Background: Anthracycline (ANT) is the most recognized therapy known to cause
cardiotoxicity, mainly left ventricle (LV) dysfunction. Global Longitudinal Strain (GLS) is the …
cardiotoxicity, mainly left ventricle (LV) dysfunction. Global Longitudinal Strain (GLS) is the …
Cardio-oncology imaging tools at the translational interface
K Yaros, B Eksi, A Chandra, K Agusala… - Journal of Molecular and …, 2022 - Elsevier
Cardiovascular imaging is an evolving component in the care of cancer patients. With
improved survival following prompt cancer treatment, patients are facing increased risks of …
improved survival following prompt cancer treatment, patients are facing increased risks of …
[HTML][HTML] Evaluating right ventricular function to reveal cancer therapy cardiotoxicity
AN Sumin - Russian Open Medical Journal, 2021 - cyberleninka.ru
Advances in cancer treatment resulted in augmented patient survival rate. However,
anticancer therapy often causes heart damage in the form of a progressive systolic heart …
anticancer therapy often causes heart damage in the form of a progressive systolic heart …